[Obstructive sleep apnea - underestimated cognitive impairments risk factor].
M A KhorevaM P KuznetsovaM V KarkavinaS S SafonovaPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2023)
About 40% of cases of cognitive impairment (CI) are associated with modifiable risk factors, such as inactivity, hypertension, diabetes and obesity. Recently, sleep disorders, including obstructive sleep apnea syndrome (OSA), have been considered among these factors. OSA is one of the most widespread conditions among patients with CI. The pathogenesis of cerebral lesions in OSA is complex. Timely diagnosis and complex therapy of patients with OSA can reduce the risk, reduce the severity of CI and slow their progression. Along with non-drug methods of treatment, the use of the drug Cortexin with a multimodal mechanism of action can minimize the negative impact of OSA on the cognitive health of patients. Early detection and treatment of OSA can reduce the severity of CI and slow their progression.
Keyphrases
- obstructive sleep apnea
- positive airway pressure
- risk factors
- sleep apnea
- cognitive impairment
- type diabetes
- end stage renal disease
- public health
- blood pressure
- metabolic syndrome
- insulin resistance
- cardiovascular disease
- newly diagnosed
- stem cells
- peritoneal dialysis
- emergency department
- depressive symptoms
- weight gain
- risk assessment
- glycemic control
- adipose tissue
- brain injury
- sleep quality
- patient reported outcomes